Authors
Latest:
Resource Use Among Nonvalvular Atrial Fibrillation PatientsThis study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Latest:
Pandemic Pricing: The Risks and Rewards of Fast-Tracking Value-Based Drug EvaluationsAs we consider the implications of the COVID-19 pandemic and the release of remdesivir, ICER’s expedited evaluation raises some questions related to value-based pricing evaluations.
Latest:
Medicare Part D Plans Burdened by Hospice Payment ReformRecent guidance and proposed rules for the Medicare hospice program will have a profound impact on plans providing Medicare Part D services.
Latest:
Probiotics for Prevention: Can You 'C' a DIFFerence?Probiotics may offer a potential treatment for clostridium difficile infection.
Latest:
Report on the 9th Annual Conference of The Pharmacy & Therapeutics SocietyRising healthcare costs, lack of standardized practice and variation in practice by geographic area (including failure to follow clinical guidelines), patient nonadherence, and continued perceptions of poor value for the money that is spent continue to plague healthcare performance, according to Joshua S. Benner, PharmD, ScD, Engelberg Center for Health Care Reform, The Brookings Institution.
Latest:
Review of Outcomes Associated With Formulary Restrictions: Focus on Step TherapyAs healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
Latest:
Prescribing At-Home COVID-19 Testing Kits for PatientsFollowing the issuance of several emergency use authorizations by the FDA that allow at-home sample collection, it is imperative for the pharmacy team to stay abreast of current testing recommendations and limitations.
Latest:
Hemophilia and Managed Care: Partnering to Achieve Cost-Effective CareExploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Latest:
Is Amazon Primed to Disrupt Specialty Pharmacy?Amazon could leverage their advanced distribution system and consumer relationship platforms to deliver specialty pharmacy services and therapies at scale.Â
Latest:
EVOLVING ROLES LEAD TO NEW OPPORTUNITIESDr. Wordell is the assistant director of Medication Use Policy, Research and Clinical Services, Department of Pharmacy, at Thomas Jefferson University Hospital.
Latest:
Rethinking Pharmacy Employee EngagementWhile often overlooked, employee engagement is a key element in determining whether a hospital, health system, or pharmacy service can effectively meet its patient access, patient quality, and organizational financial demands.
Latest:
Patient Preference for Treatment Administration in Cystic FibrosisThis study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.
Latest:
Value-Based Insurance Design: Improving Adherence Through Shifting Benefit DesignsThe past several decades have seen unprecedented advances in therapeutic and technological solutions to the diagnosis, treatment, and prevention of human disease.
Latest:
Community Pharmacist Involvement in Prescription Drug Monitoring ProgramsThe involvement of community pharmacists is vital to reduce prescription drug abuse through the use of Electronic Prescription Drug Monitoring Programs.
Latest:
Topical CorticosteroidsTopical corticosteroids are available over the counter and are prescribed for a variety of skin ailments ranging from mild and irritating to severe and debilitating.
Latest:
What Patients Should Know About Generic Drugs: A Resource Guide for PharmacistsA wealth of resource is available to help pharmacists build public trust in the quality and efficacy of generic medications.
Latest:
'Tweezer' Molecule May Improve Infectious Disease PreventionResearch may lead to gel that prevents transmission of HIV, hepatitis C and the Ebola virus.
Latest:
Management of Unresectable Locoregionally Advanced and Metastatic Nonsquamous NSCLCEfficacy, toxicity, and costs are all important components of formulating an appropriate care pathway for unresectable locoregionally advanced and metastatic NSCLC.
Latest:
Help Manage and Treat Parkinson DiseasePharmacists play an integral role and can improve patients’ quality of life with proper communication, counseling, and monitoring.
Latest:
E-Prescribing Is Becoming a Standard of CareE-prescribing adoption has increased dramatically over the past decade. This study provides empirical evidence that utilization among adopters continues to increase, suggesting application “stickiness.â€
Latest:
Promoting Brain Function Is Key Amid COVID-19 CrisisNecessary measures taken during the pandemic may exacerbate some underlying factors that can lead to decline.
Latest:
Zooming Through the Pandemic: NSU Virtual AMCP Student ChapterThere are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Latest:
OTC Drug Monograph Reform Is on the HorizonThe success of PDUFA raises questions about additional funding to market nonprescription products.
Latest:
Lung Cancer Treatment Is Continuously Moving ForwardAs treatments for lung cancer move forward and patient care services continue to expand, the role of the pharmacist in oncology is critical.
Latest:
Opioid-Induced Constipation: Considerations for Formulary Decision MakersThis activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.
Latest:
Acne: More than a Cosmetic ProblemPeople of all ages can develop acne, but many treatments are available.
